ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Csl Ltd (QX)

Csl Ltd (QX) (CMXHF)

160.00
0.00
(0.00%)
마감 27 2월 6:00AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
160.00
매수가
155.00
매도가
172.90
거래량
-
0.00 일간 변동폭 0.00
153.23 52주 범위 210.49
market_cap
전일 종가
160.00
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
797
발행 주식
483,252,729
배당수익률
1.72%
주가수익률
47.62
주당순이익(EPS)
5.47
매출
14.69B
순이익
2.64B

Csl Ltd (QX) 정보

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
본부
Melbourne, Victoria, Aus
설립됨
1916
Csl Ltd (QX) is listed in the Biological Pds,ex Diagnstics sector of the OTC 시장 with ticker CMXHF. The last closing price for Csl (QX) was US$160. Over the last year, Csl (QX) shares have traded in a share price range of US$ 153.23 to US$ 210.49.

Csl (QX) currently has 483,252,729 shares in issue. The market capitalisation of Csl (QX) is US$77.32 billion. Csl (QX) has a price to earnings ratio (PE ratio) of 47.62.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-12.356-7.16888300958172.356172.356158.8346159.28901832CS
4-14.22-8.16209390426174.22179.72153.231349166.67490272CS
12-20-11.1111111111180180.02153.23797168.22024796CS
26-44.22-21.6531191852204.22209.95153.23684178.22580199CS
52-22.29-12.2277689396182.29210.49153.23716183.55306658CS
156-23.5-12.8065395095183.5217.815144.81739185.21380487CS
260-44-21.568627451204239.41144.81541189.84497356CS

CMXHF - Frequently Asked Questions (FAQ)

What is the current Csl (QX) share price?
The current share price of Csl (QX) is US$ 160.00
How many Csl (QX) shares are in issue?
Csl (QX) has 483,252,729 shares in issue
What is the market cap of Csl (QX)?
The market capitalisation of Csl (QX) is USD 77.32B
What is the 1 year trading range for Csl (QX) share price?
Csl (QX) has traded in the range of US$ 153.23 to US$ 210.49 during the past year
What is the PE ratio of Csl (QX)?
The price to earnings ratio of Csl (QX) is 47.62
What is the cash to sales ratio of Csl (QX)?
The cash to sales ratio of Csl (QX) is 8.56
What is the reporting currency for Csl (QX)?
Csl (QX) reports financial results in USD
What is the latest annual turnover for Csl (QX)?
The latest annual turnover of Csl (QX) is USD 14.69B
What is the latest annual profit for Csl (QX)?
The latest annual profit of Csl (QX) is USD 2.64B
What is the registered address of Csl (QX)?
The registered address for Csl (QX) is 655 ELIZABETH STREET, MELBOURNE, VICTORIA, 3000
What is the Csl (QX) website address?
The website address for Csl (QX) is www.csl.com.au
Which industry sector does Csl (QX) operate in?
Csl (QX) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AABVFAberdeen International Inc (PK)
US$ 0.02282
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0244
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.02282
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0244
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.02282
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0244
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
Pro_v12001 Pro_v12001 3 분 전
Walter, have you been able to speak with Michael since his departure from the company and if so would you be willing to share with us any insight from that conversation as it relates to Lightwave.
LWLG
ALDRADJKD123 ALDRADJKD123 3 분 전
You have to remember all of the misleading that was done on his part,

Claimed in 2016 that Nioturd was on the cusp of full and complete funding, then claimed just a few years ago how the NASDAQ was going to be the game changer. Both turned out to be false and very misleading.
NB
DRHUMI DRHUMI 4 분 전
Why are you and Price and Homebrew the Warrior Moderator so lonely that you have to hang around a DEAD stock board?
ENZC
Sos28493 Sos28493 5 분 전
Can you explain what you meant by this line?  
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px"

style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-seri
VPLM
Juntao Juntao 5 분 전
not bad, like 1% of float
AIBT
stock_observer_77 stock_observer_77 6 분 전
People make their own choices....I've never seen ANY pumping here
DonVance DonVance 6 분 전
Is this company named after Knight Rider?
KITT
dmb2 dmb2 8 분 전
Do you see the stakes being raised to include spillover into criminal investigations?

Thx

GLTA
NWBO
uranium-pinto-beans uranium-pinto-beans 9 분 전
goooooooooooooooooooooooood morning bobber
HGilS HGilS 9 분 전
Great findings Mrwrn2010!!!!
ELTP
sirant sirant 10 분 전
GOOD MORNING EVERYONE 

GO $MCIC 
MCIC
glenn1919 glenn1919 12 분 전
VMAR.......KULR......BMRA......PRCH.......ULY.......ATCH........https://stockcharts.com/h-sc/ui?s=ATCH&p=D&yr=0&mn=2&dy=12&id=p84071410134
ATCH BMRA KULR
uranium-pinto-beans uranium-pinto-beans 12 분 전
SNOW
Snowflake price target raised to $203 from $190 at Barclays
Barclays raised the firm's price target on Snowflake to $203 from $190 and keeps an Overweight rating on the shares. The company reported a "healthy" Q4 and delivered fiscal 2026 sales guidance ahead of Street expectat
WooptdooU WooptdooU 13 분 전
Starting to panic? Pity, really.
LWLG
cottonmather cottonmather 13 분 전
Several Dairy Queen groups are closing/filing bankruptcy. Don't worry. Everything is fine. Idiots.
NCLH
ollik78 ollik78 13 분 전
Hope you bought 
$RILY at 3 or 4 
🤭🚀💵

B. Riley Financial Announces $160 Million Debt Financing Provided by Oaktree
RILY
uranium-pinto-beans uranium-pinto-beans 13 분 전
NVDA
Nvidia price target raised to $162 from $152 at Morgan Stanley
Morgan Stanley raised the firm's price target on Nvidia to $162 from $152 and keeps an Overweight rating on the shares. Q4 revenues were slightly better than the firm previewed, with gross margins slightly worse, th
NVDA
TOM611 TOM611 14 분 전
Rnaz will bounce higher today. Go. Rnaz
RNAZ
ExtremelyBullishZig ExtremelyBullishZig 14 분 전
Well....it remains safe...not all endpoints (especially the failed primary endpoints) or the placebo arm point to effective for AD...and definitely not effective for Rett. Trials for PD took forever to get going and still aren't started...What are they hiding?
AVXL
SC8 SC8 14 분 전
Doesn't matter the science. This is a business. Gotta follow the Benjamins. That's all that matters
RDGL
TOM611 TOM611 14 분 전
2.89 is a gift i added. 800. Shares.  Go. RNAZ
RNAZ
dmb2 dmb2 15 분 전
hyperopia, thx much for the factual response. Your patience, technical understanding and writing are very helpful to all here.
Given the timing now vs when NWBO published their 2/24 PR, do you think it is too optimistic to think the re-inspection may have been due to FW qualification?
NWBO

최근 히스토리

Delayed Upgrade Clock